文献速递甲状腺疾病

CUT评分在细胞学不确定甲状腺结节术前决策中的应用

Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment?
PubMed 文献 · Thyroid · 2019-10-23

该研究将CUT评分应用于201个细胞学不确定甲状腺结节(78个TIR3A、123个TIR3B),比较C+U评分在良恶性结节间的差异。恶性结节C+U中位值显著高于良性(TIR3A 4.37 vs 2.75;TIR3B 4.50 vs 3.00)。ROC分析确定TIR3A cutoff为≥4.00(敏感性56%、特异性77%、AUC=0.714),TIR3B为≥3.75(敏感性65%、特异性78%、AUC=0.744)。CUT评分或可辅助不确定结节的管理决策。

要点

  • 恶性结节C+U评分中位值显著高于良性结节。
  • TIR3A组cutoff≥4.00,敏感性56%、特异性77%。
  • TIR3B组cutoff≥3.75,敏感性65%、特异性78%。

核心结论

  • CUT评分可能为临床医生管理伴滤泡增生的不确定结节提供有效辅助。

研究设计与样本

  • 回顾性应用CUT评分于201个细胞学不确定甲状腺结节,其中TIR3A 78个、TIR3B 123个。
  • 采用Mann-Whitney检验比较两组C+U评分,并用ROC曲线验证C+U评分的诊断效能。

主要发现

  • TIR3A组恶性结节C+U中位值4.37,良性2.75,差异显著。
  • TIR3B组恶性结节C+U中位值4.50,良性3.00,差异显著。
  • TIR3A组ROC分析确定C+U≥4.00为恶性诊断cutoff(敏感性56%、特异性77%、AUC=0.714)。
  • TIR3B组ROC分析确定C+U≥3.75为恶性诊断cutoff(敏感性65%、特异性78%、AUC=0.744)。

关键数值与推荐

  • TIR3A组:C+U≥4.00,敏感性56%、特异性77%、AUC=0.714。
  • TIR3B组:C+U≥3.75,敏感性65%、特异性78%、AUC=0.744。

临床怎么用

  • 对细胞学不确定的TIR3A/TIR3B结节,可参考CUT评分C+U值辅助术前恶性风险评估。
  • TIR3A结节C+U≥4.00或提示较高恶性风险,可考虑更积极干预。
  • TIR3B结节C+U≥3.75或提示较高恶性风险,可考虑更积极干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The CUT score is a thyroid nodule scoring system that has become recently available as a smartphone application. It has been created on the basis of a clinical (C) and ultrasonographic (U) meta-analysis of suspicious thyroid nodule features to help clinicians with the preoperative malignancy risk assessment of thyroid nodules. The aim of the present study was to analyze the C + U sum of the CUT score for cytologically indeterminate TIR3A and TIR3B thyroid nodules, comparing the results obtained from the two groups. Methods: The CUT score was applied to 201 cytologically indeterminate thyroid nodules, 78 categorized as TIR3A and 123 as TIR3B. The Mann-Whitney test was applied to compare the C + U score values of the two groups, and a receiver operating characteristic (ROC) curve analysis was performed to validate the C + U score as a diagnostic test. Results: In both groups, the median C + U value of all nodules was significantly higher in case of malignant (4.37 TIR3A, 4.50 TIR3B) versus benign nodules (2.75 TIR3A, 3.00 TIR3B). Through ROC curve analysis within the TIR3A group, a C + U value ≥4.00 was determined as diagnostic cutoff for the detection of malignant nodules (56% sensitivity, 77% specificity, area under the curve [AUC] = 0.714); and for the TIR3B group, a cutoff of C + U value of ≥3.75 was identified (65% sensitivity, 78% specificity, AUC = 0.744). Conclusion: The CUT score could represent a valid aid for the clinician in the management of indeterminate nodules with follicular proliferation.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ianni F, Pascucci D, Paragliola RM, et al. Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment? Thyroid. 2019. PMID: 31552809. doi:10.1089/thy.2018.0649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。